The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection

Journal of Leukocyte Biology

Volumn 74, Issue 5, 2003, Pages 750-756

  Alfano, Massimo ^a   Sidenius, Nicolai ^a   Blasi, Francesco ^a,b   Poli, Guido ^a,b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c P2 P3 Laboratories   (Italy)

Author keywords

Interferon; Lymphocyte; Macrophage

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CHEMOKINE; CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN GP 120; GLYCOSYLPHOSPHATIDYLINOSITOL; SUPPRESSOR FACTOR; UROKINASE RECEPTOR;

AMINO TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION;

CHEMOKINES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0347320926     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0403176     Document Type: Conference Paper

References (82)

1. Collen, D. (1999) The plasminogen (fibrinolytic) system. Thromb. Haemost. 82, 259-270.
2. Blasi, F., Carmeliet, P. (2002) uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943.
3. Petersen, L. C. (1997) Kinetics of reciprocal pro- urokinase/plasminogen activation-stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Eur. J. Biochem. 245, 316-323.
4. Cubellis, M. V., Andreasen, P., Ragno, P., Mayer, M., Dano, K., Blasi, F. (1989) Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA 86, 4828-4832.
5. Ellis, V., Wun, T. C., Behrendt, N., Ronne, E., Dano, K. (1990) Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J. Biol. Chem. 265, 9904-9908.
6. Baker, M. S., Bleakley, P., Woodrow, G. C., Doe, W. F. (1990) Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Res. 50, 4676-4684.
7. Cubellis, M. V., Wun, T. C., Blasi, F. (1990) Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 9, 1079-1085.
8. Olson, D., Pollanen, J., Hoyer-Hansen, G., Ronne, E., Sakaguchi, K., Wun, T. C., Appella, E., Dano, K., Blasi, F. (1992) Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J. Biol. Chem. 267, 9129-9133.
9. Nykjaer, A., Petersen, C. M., Moller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thogersen, H. C., Munch, M., Andreasen, P. A., et al. (1992) Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543-14546.
10. Nykjaer, A., Conese, M., Christensen, E. I., Olson, D., Cremona, O., Gliemann, J., Blasi, F. (1997) Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 16, 2610-2620.
11. Ploug, M., Ellis, V. (1994) Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett. 349, 163-168.
12. Estreicher, A., Muhlhauser, J., Carpentier, J. L., Orci, L., Vassalli, J. D. (1990) The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111, 783-792.
13. Martin, T. J., Allan, E. H., Fukumoto, S. (1993) The plasminogen activator and inhibitor system in bone remodelling. Growth Regul. 3, 209-214.
14. Tkachuk, V., Stepanova, V., Little, P. J., Bobik, A. (1996) Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin. Exp. Pharmacol. Physiol. 23, 759-765,
15. Shen, G. X. (1998) Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review). Int. J. Mol. Med. 1, 399-408.
16. Ossowski, L. (1988) Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo, Cell 52, 321-328.
17. Falcone, D. J., McCaffrey, T. A., Haimovitz-Friedman, A., Vergilio, J. A., Nicholson, A. C. (1993) Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J. Biol. Chem. 268, 11951-11958.
18. Odekon, L. E., Blasi, F., Rifkin, D. B. (1994) Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J. Cell. Physiol. 158, 398-407.
19. Pluskota, E., Soloviev, D. A., Plow, E. F. (2003) Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood 101, 1582-1590.
20. Waltz, D. A., Chapman, H. A. (1994) Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269, 14746-14750.
21. Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., Chapman, H. A. (1996) Regulation of integrin function by the urokinase receptor. Science 273, 1551-1555.
22. Nusrat, A. R., Chapman, H. A., Jr. (1991) An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87, 1091-1097.
23. Farias-Eisner, R., Vician, L., Silver, A., Reddy, S., Rabbani, S. A., Herschman, H. R. (2000) The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation. J. Neurosci. 20, 230-239.
24. Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J., Goltzman, D. (1992) Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267, 14151-14156.
25. Kirchheimer, J. C., Wojta, J., Hienert, G., Christ, G., Heger, M. E., Pfluger, H., Binder, B. R. (1987) Effect of urokinase on the proliferation of primary cultures of human prostatic cells. Thromb. Res. 48, 291-298.
26. Sidenius, N., Andolfo, A., Fesce, R., Blasi, F. (2002) Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J. Biol. Chem. 277, 27982-27990.
27. Ploug, M., Ronne, E., Behrendt, N., Jensen, A. L., Blasi, F., Dano, K. (1991) Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266, 1926-1933.
28. Wei, Y., Yang, X., Liu, Q., Wilkins, J. A., Chapman, H. A. (1999) A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144, 1285-1294.
29. Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., Witztum, J. L. (2003) Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561-1568.
30. Degryse, B., Resnati, M., Rabbani, S. A., Villa, A., Fazioli, F., Blasi, F. (1999) Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 94, 649-662.
31. Resnati, M., Pallavicini, I., Wang, J. M., Oppenheim, J., Serhan, C. N., Romano, M., Blasi, F. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. USA 99, 1359-1364.
32. Simon, D. I., Wei, Y., Zhang, L., Rao, N. K., Xu, H., Chen, Z., Liu, Q., Rosenberg, S., Chapman, H. A. (2000) Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275, 10228-10234.
33. Bender, F., Montoya, M., Monardes, V., Leyton, L., Quest, A. F. (2002) Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35, 151-167.
34. Stahl, A., Mueller, B. M. (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell Biol. 129, 335-344.
35. Degryse, B., Orlando, S., Resnati, M., Rabbani, S. A., Blasi, F. (2001) Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene 20, 2032-2043.
36. Yebra, M., Parry, G. C., Stromblad, S., Mackman, N., Rosenberg, S., Mueller, B. M., Cheresh, D. A. (1996) Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J. Biol. Chem. 271, 29393-29399.
37. Liu, D., Aguirre Chiso, J., Estrada, Y., Ossowski, L. (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1, 445-457.
38. Kjoller, L., Hall, A. (2001) Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 152, 1145-1157.
39. Nguyen, D. H., Webb, D. J., Catling, A. D., Song, Q., Dhakephalkar, A., Weber, M. J., Ravichandran, K. S., Gonias, S. L. (2000) Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J. Biol. Chem. 275, 19382-19388.
40. Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C., Binder, B. R. (1997) Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272, 28563-28567.
41. Dumler, I., Weis, A., Mayboroda, O. A., Maasch, C., Jerke, U., Haller, H., Gulba, D. C. (1998) The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273, 315-321.
42. Cross, A. K., Woodroofe, M. N. (1999) Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28, 183-189.
43. Locati, M., Deuschle, U., Massardi, M. L., Martinez, F. O., Sironi, M., Sozzani, S., Bartfai, T., Mantovani, A. (2002) Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168, 3557-3562.
44. Ferland, C., Guilbert, M., Davoine, F., Flamand, N., Chakir, J., Laviolette, M. (2001) Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. J. Leukoc. Biol. 69, 772-778.
45. Vakili, J., Standker, L., Detheux, M., Vassart, G., Forssmann, W. G., Parmentier, M. (2001) Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active. J. Immunol. 167, 3406-3413.
46. Speth, C., Pichler, I., Stockl, G., Mair, M., Dierich, M. P. (1998) Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology 199, 152-162.
47. Mengozzi, M., De Filippi, C., Transidico, P., Biswas, P., Cota, M., Ghezzi, S., Vicenzi, E., Mantovani, A., Sozzani, S., Poli, G. (1999) Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood 93, 1851-1857.
48. Canque, B., Rosenzwajg, M., Gey, A., Tartour, E., Fridman, W. H., Gluckman, J. C. (1996) Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 87, 2011-2019.
49. Swingler, S., Mann, A., Jacque, J., Brichacek, B., Sasseville, V. G., Williams, K., Lackner, A. A., Janoff, E. N., Wang, R., Fisher, D., et al. (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5, 997-1003.
50. + precursors and is down-regulated upon maturation. J. Immunol. 164, 712-718.
51. Kinter, A., Catanzaro, A., Monaco, J., Ruiz, M., Justement, J., Moir, S., Arthos, J., Oliva, A., Ehler, L., Mizell, S., et al. (1998) CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 95, 11880-11885.
52. Vicenzi, E., Alfano, M., Ghezzi, S., Gatti, A., Veglia, F., Lazzarin, A., Sozzani, S., Mantovani, A., Poli, G. (2000) Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1. J. Leukoc. Biol. 68, 405-412.
53. Fantuzzi, L., Spadaro, F., Vallanti, G., Canini, I., Ramoni, C., Vicenzi, E., Belardelli, F., Poli, G., Gessani, S. (2003) Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood Epub ahead of print
54. Bernasconi, S., Cinque, P., Peri, G., Sozzani, S., Crociati, A., Torri, W., Vicenzi, E., Vago, L., Lazzarin, A., Poli, G., et al. (1996) Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J. Infect. Dis. 174, 1098-1101.
55. Cinque, P., Vago, L., Mengozzi, M., Torri, V., Ceresa, D., Vicenzi, E., Transidico, P., Vagani, A., Sozzani, S., Mantovani, A., et al. (1998) Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12, 1327-1332.
56. Stephens, R. W., Nielsen, H. J., Christensen, I. J., Thorlacius-Ussing, O., Sorensen, S., Dano, K., Brunner, N. (1999) Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J. Natl. Cancer Inst. 91, 869-874.
57. Gyetko, M. R., Chen, G. H., McDonald, R. A., Goodman, R., Huffnagle, G. B., Wilkinson, C. C., Fuller, J. A., Toews, G. B. (1996) Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J. Clin. Invest. 97, 1818-1826.
58. Sidenius, N., Sier, C. F., Ullum, H., Pedersen, B. K., Lepri, A. C., Blasi, F., Eugen-Olsen, J. (2000) Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96, 4091-4095 (In Process Citation).
59. Baier-Bitterlich, G., Wachter, H., Fuchs, D. (1996) Role of neopterin and 7,8-dihydroneopterin in human immunodeficiency virus infection: marker for disease progression and pathogenic link. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13, 184-193.
60. Nykjaer, A., Moller, B., Todd, R. F., III, Christensen, T., Andreasen, P. A., Gliemann, J., Petersen, C. M. (1994) Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol. 152, 505-516.
61. Storgaard, M., Obel, N., Black, F. T., Moller, B. K. (2002) Decreased urokinase receptor expression on granulocytes in HIV-infected patients. Scand. J. Immunol. 55, 409-413.
62. Murali, R., Wolfe, J. H., Erber, R., Chice, S. M., Murali, M. R., Durkin, H. G., Zach, P., Auci, D. L. (1998) Altered levels of urokinase on monocytes and in serum of children with AIDS; effects on lymphocyte activation and surface marker expression. J. Leukoc. Biol. 64, 198-202.
63. Handley, M. A., Steigbigel, R. T., Morrison, S. A. (1996) A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages. J. Virol. 70, 4451-4456.
64. Sodeik, B. (2002) Unchain my heart, baby let me go-the entry and intracellular transport of HIV. J. Cell Biol. 159, 393-395.
65. Pereira, L. A., Bentley, K., Peeters, A., Churchill, M. J., Deacon, N. J. (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28, 663-668.
66. Pollard, V. W., Malim, M. H. (1998) The HIV-1 Rev protein. Annu. Rev. Microbiol. 52, 491-532.
67. Freed, E. O. (2002) Viral late domains. J. Virol. 76, 4679-4687.
68. Ono, A., Freed, E. O. (2001) Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98, 13925-13930.
69. Nguyen, D. H., Hildreth, J. E. (2000) Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74, 3264-3272.
70. Denzer, K., Kleijmeer, M. J., Heijnen, H. F., Stoorvogel, W., Geuze, H. J. (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113, 3365-3374.
71. Levy, J. A., Mackewicz, C. E., Barker, E. (1996) Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17, 217-224.
72. Wada, M., Wada, N. A., Shirono, H., Taniguchi, K., Tsuchie, H., Koga, J. (2001) Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication. Biochem. Biophys. Res. Commun. 284, 346-351.
73. Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A., Fauci, A. S. (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238, 800-802.
74. Alfano, M., Poli, G. (2002) The cytokine network in HIV infection. Curr. Mol. Med. 2, 677-689.
75. Alfano, M., Sidenius, N., Panzeri, B., Blasi, F., Poli, G. (2002) Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc. Natl. Acad. Sci. USA 99, 8862-8867.
76. Glushakova, S., Baibakov, B., Margolis, L. B., Zimmerberg, J. (1995) Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat. Med. 1, 1320-1322.
77. Franzoso, G., Biswas, P., Poli, G., Carlson, L. M., Brown, K. D., Tomita-Yamaguchi, M., Fauci, A. S., Siebenlist, U. K. (1994) A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells. J. Exp. Med. 180, 1445-1456.
78. Biswas, P., Mantelli, B., Delfanti, F., Cota, M., Vallanti, G., de Filippi, C., Mengozzi, M., Vicenzi, E., Lazzarin, A., Poli, G. (2001) Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4. Cytokine 13, 55-59.
79. Biswas, P., Mengozzi, M., Mantelli, B., Delfanti, F., Brambilla, A., Vicenzi, E., Poli, G. (1998) 1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-kappaB-independent enhancement of viral replication. J. Virol. 72, 8380-8383.
80. Biswas, P., Poli, G., Kinter, A. L., Justement, J. S., Stanley, S. K., Maury, W. J., Bressler, P., Orenstein, J. M., Fauci, A. S. (1992) Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176, 739-750.
81. Bovolenta, C., Lorini, A. L., Mantelli, B., Camorali, L., Novelli, F., Biswas, P., Poli, G. (1999) A selective defect of IFN-gamma-but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. J. Immunol. 162, 323-330.
82. Sitrin, R. G., Pan, P. M., Srikanth, S., Todd, R. F., III (1998) Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J. Immunol. 161, 1462-1470.